EcoDrugPlus

Receptor Activity-Modifying Protein 1-Like

Ensembl ID : ENSPKIG00000014837
Gene Symbol: LOC111851600
3 Cross references
252 Possible Orthologues:

Receptor Interacting Serine/threonine Kinase 1

Ensembl ID : ENSPKIG00000004307
Gene Symbol: RIPK1
3 Cross references
196 Possible Orthologues:

Regulatory Associated Protein Of Mtor Complex 1

Ensembl ID : ENSPKIG00000006509
Gene Symbol: RPTOR
1 Cross references
213 Possible Orthologues:

Renin

Ensembl ID : ENSPKIG00000011976
Gene Symbol: REN
3 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSPKIG00000007875
Gene Symbol: RET
3 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Rxr-Alpha-A

Ensembl ID : ENSPKIG00000008675
Gene Symbol: LOC111842673
2 Cross references
175 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSPKIG00000009963
Gene Symbol: RARB
4 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSPKIG00000010626
Gene Symbol: LOC111839084
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPKIG00000003438
Gene Symbol: RARG
3 Cross references
311 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSPKIG00000006513
Gene Symbol: RARG
1 Cross references
378 Possible Orthologues:

Retinoid X Receptor Alpha

Ensembl ID : ENSPKIG00000018422
Gene Symbol: RXRA
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L10

Ensembl ID : ENSPKIG00000006371
Gene Symbol: RPL10
3 Cross references
409 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).